| Tretinoin | Approved Investigational Nutraceutical | NAT8L | 339983 |
downregulated | Tretinoin results in decreased expression of NAT8L mRNA | 4p16.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NAV1 | 89796 |
downregulated | Tretinoin results in decreased expression of NAV1 mRNA | 1q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NAV2 | 89797 |
upregulated | Tretinoin results in increased expression of NAV2 mRNA | 11p15.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NAV3 | 89795 |
downregulated | Tretinoin results in decreased expression of NAV3 mRNA | 12q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NBL1 | 4681 |
upregulated | Tretinoin results in increased expression of NBL1 mRNA | 1p36.13 | |
| Tretinoin | Approved Investigational Nutraceutical | NBPF10 | 100132406 |
upregulated | Tretinoin results in increased expression of NBPF10 mRNA | 1q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NCALD | 83988 |
downregulated | Tretinoin results in decreased expression of NCALD mRNA | 8q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NCAM1 | 4684 |
upregulated | Tretinoin results in increased expression of NCAM1 mRNA | 11q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NCAM2 | 4685 |
upregulated | Tretinoin results in increased expression of NCAM2 mRNA | 21q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NCAN | 1463 |
downregulated | Tretinoin results in decreased expression of NCAN mRNA | 19p12 | |
| Tretinoin | Approved Investigational Nutraceutical | NCBP1 | 4686 |
downregulated | Tretinoin results in decreased expression of NCBP1 mRNA | 9q22.33 | |
| Tretinoin | Approved Investigational Nutraceutical | NCBP2 | 22916 |
downregulated | Tretinoin results in decreased expression of NCBP2 mRNA | 3q29 | |
| Tretinoin | Approved Investigational Nutraceutical | NCF1 | 653361 |
upregulated | Tretinoin results in increased expression of NCF1 mRNA | 7q11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | NCF2 | 4688 |
upregulated | Tretinoin results in increased expression of NCF2 mRNA | 1q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NCK1 | 4690 |
downregulated | Tretinoin results in decreased expression of NCK1 mRNA | 3q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NCOA3 | 8202 |
upregulated | Tretinoin results in increased expression of NCOA3 mRNA | 20q13.12 | |
| Tretinoin | Approved Investigational Nutraceutical | NCOA6 | 23054 |
downregulated | Tretinoin results in decreased expression of NCOA6 mRNA | 20q11.22 | |
| Tretinoin | Approved Investigational Nutraceutical | NCOA7 | 135112 |
upregulated | Tretinoin results in increased expression of NCOA7 mRNA | 6q22.31-q22.32 | |
| Tretinoin | Approved Investigational Nutraceutical | NDFIP1 | 80762 |
upregulated | Tretinoin results in increased expression of NDFIP1 mRNA | 5q31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NDFIP2 | 54602 |
upregulated | Tretinoin results in increased expression of NDFIP2 mRNA | 13q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NDRG1 | 10397 |
upregulated | Tretinoin results in increased expression of NDRG1 mRNA | 8q24.22 | |
| Tretinoin | Approved Investigational Nutraceutical | NDRG2 | 57447 |
upregulated | Tretinoin results in increased expression of NDRG2 mRNA | 14q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NDRG4 | 65009 |
upregulated | Tretinoin results in increased expression of NDRG4 mRNA | 16q21 | |
| Tretinoin | Approved Investigational Nutraceutical | NDUFA3 | 4696 |
downregulated | Tretinoin results in decreased expression of NDUFA3 mRNA | 19q13.42 | |
| Tretinoin | Approved Investigational Nutraceutical | NDUFAF2 | 91942 |
downregulated | Tretinoin results in decreased expression of NDUFAF2 mRNA | 5q12.1 | |